UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial

PloS one, 2016-06, Vol.11 (6), p.e0157063-e0157063

2016

Volltextzugriff (PDF)

Analytical and Biological Variation in Measures of Anemia and Iron Status in Patients Treated With Maintenance Hemodialysis

American journal of kidney diseases, 2010-09, Vol.56 (3), p.540-546

2010

Volltextzugriff (PDF)

Impact of Rescheduling a Missed Hemodialysis Treatment on Clinical Outcomes

Kidney medicine, 2020-01, Vol.2 (1), p.12-19

2020

Volltextzugriff (PDF)

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

Transfusion (Philadelphia, Pa.), 2009-12, Vol.49 (12), p.2719-2728

2009

Volltextzugriff (PDF)

Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection

Journal of the American Society of Nephrology, 2018-04, Vol.29 (4), p.1336-1343

2018

Volltextzugriff (PDF)

Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2007-08, Vol.110 (2 Pt 1), p.267-278

2007

Volltextzugriff (PDF)

Urgent-start peritoneal dialysis: Association with outcomes

Peritoneal dialysis international, 2023-03, Vol.43 (2), p.186-189

2023

Volltextzugriff (PDF)

A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD

Kidney international, 2005-12, Vol.68 (6), p.2846-2856

2005

Volltextzugriff (PDF)

Effect of Intravenous Iron Sucrose in Peritoneal Dialysis Patients Who Receive Erythropoiesis-Stimulating Agents for Anemia: A Randomized, Controlled Trial

Clinical journal of the American Society of Nephrology, 2006-05, Vol.1 (3), p.475-482

2006

Volltextzugriff (PDF)

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

Nephrology, dialysis, transplantation, 2017-09, Vol.32 (9), p.1530-1539

2017

Volltextzugriff (PDF)

Labile iron: manifestations and clinical implications

Journal of the American Society of Nephrology, 2004-12, Vol.15 Suppl 2, p.S107-S111

Van Wyck, David B

2004

Volltextzugriff (PDF)

Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical Trial

American journal of kidney diseases, 2001-02, Vol.37 (2), p.300-307

2001

Volltextzugriff (PDF)

Knowing What We Do and Doing What We Should: Quality Assurance in Hemodialysis

Nephron, 2014-01, Vol.126 (3), p.135-143

2014

Volltextzugriff (PDF)

Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients

Nephrology, dialysis, transplantation, 2005-07, Vol.20 (7), p.1438-1442

2005

Volltextzugriff (PDF)

Comparative Effectiveness of Ad26.COV2.S vs. BNT162b2 for the Prevention of SARS-CoV-2 Infection Among Dialysis Patients: PO0132

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.95-95

2021

Volltextzugriff (PDF)

Association Between Antimicrobial Barrier Cap Use and Outcomes Among Hemodialysis Patients Using a Central Venous Catheter: SU-OR30

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.53-53

2020

Volltextzugriff (PDF)

BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

Transfusion (Philadelphia, Pa.), 2009-12, Vol.49 (12), p.2719-2728

2009

Volltextzugriff (PDF)

Urgent-Start Peritoneal Dialysis and Outcomes: PO1261

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.418-418

2020

Volltextzugriff (PDF)

Making sense: a scientific approach to intravenous iron therapy

Journal of the American Society of Nephrology, 2004-12, Vol.15 Suppl 2, p.S91-S92

2004

Volltextzugriff (PDF)

Just the FAQs: Frequently asked questions about iron and anemia in patients with chronic kidney disease

American journal of kidney diseases, 2002-02, Vol.39 (2), p.426-432

2002

Volltextzugriff (PDF)

Error, not iron, generates cytotoxicity

American journal of kidney diseases, 2002-11, Vol.40 (5), p.1109-1110

Van Wyck, David B.

2002

Volltextzugriff (PDF)

Labile iron in parenteral iron formulations: a quantitative and comparative study

Nephrology, dialysis, transplantation, 2004-03, Vol.19 (3), p.561-565

2004

Volltextzugriff (PDF)

Iron status in patients receiving erythropoietin for dialysis-associated anemia

Kidney international, 1989-02, Vol.35 (2), p.712-716

1989

Volltextzugriff (PDF)

Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapy

Nephrology, dialysis, transplantation, 2000-01, Vol.15 (suppl-3), p.36-39

VAN WYCK, David B

2000

Volltextzugriff (PDF)

SO035THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD): 1-YEAR RESULTS FROM THE FIND-CKD TRIAL

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i15-i16

2016

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(28)
Urology & Nephrology
(24)
Biological And Medical Sciences
(18)
Male
(17)
Medical Sciences
(17)
Female
(14)
Middle Aged
(11)
Injections, Intravenous
(10)
Ferric Compounds - Administration & Dosage
(9)
Aged
(8)
Anemia
(8)
Anemia, Iron-Deficiency - Drug Therapy
(8)
Animals
(8)
Erythropoietin - Therapeutic Use
(8)
Pharmacology. Drug Treatments
(8)
Prospective Studies
(8)
Adult
(7)
Anemia, Iron-Deficiency - Etiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial

Analytical and Biological Variation in Measures of Anemia and Iron Status in Patients Treated With Maintenance Hemodialysis

Impact of Rescheduling a Missed Hemodialysis Treatment on Clinical Outcomes

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection

Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial

Urgent-start peritoneal dialysis: Association with outcomes

A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD

Effect of Intravenous Iron Sucrose in Peritoneal Dialysis Patients Who Receive Erythropoiesis-Stimulating Agents for Anemia: A Randomized, Controlled Trial

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

Labile iron: manifestations and clinical implications

Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical Trial

Knowing What We Do and Doing What We Should: Quality Assurance in Hemodialysis

Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients

Comparative Effectiveness of Ad26.COV2.S vs. BNT162b2 for the Prevention of SARS-CoV-2 Infection Among Dialysis Patients: PO0132

Association Between Antimicrobial Barrier Cap Use and Outcomes Among Hemodialysis Patients Using a Central Venous Catheter: SU-OR30

BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

Urgent-Start Peritoneal Dialysis and Outcomes: PO1261

Making sense: a scientific approach to intravenous iron therapy

Just the FAQs: Frequently asked questions about iron and anemia in patients with chronic kidney disease

Error, not iron, generates cytotoxicity

Labile iron in parenteral iron formulations: a quantitative and comparative study

Iron status in patients receiving erythropoietin for dialysis-associated anemia

Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapy

SO035THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD): 1-YEAR RESULTS FROM THE FIND-CKD TRIAL

Suchergebnisse filtern